Predictors of relapse and efficacy of rituximab in immune thrombotic thrombocytopenic purpura

Patients with immune-mediated thrombotic thrombocytopenic purpura (iTTP) often experience life-threatening relapses of the disease, and rituximab (RTX) can be used to mitigate relapse risk. However, the predictors of relapse in iTTP and the magnitude and duration of effect of RTX remain key unanswer...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Blood Adv
Main Authors: Sun, Lova, Mack, Johnathan, Li, Ang, Ryu, Justine, Upadhyay, Vivek A., Uhl, Lynne, Kaufman, Richard M., Stowell, Christopher P., Dzik, Walter S., Makar, Robert S., Bendapudi, Pavan K.
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Hematology 2019
Fag:
Thrombosis and Hemostasis
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6517661/
https://ncbi.nlm.nih.gov/pubmed/31076407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019031039
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker